186 related articles for article (PubMed ID: 16264203)
1. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction.
Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C
J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203
[TBL] [Abstract][Full Text] [Related]
2. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
[TBL] [Abstract][Full Text] [Related]
3. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
[TBL] [Abstract][Full Text] [Related]
4. The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.
Vinholt P; Poulsen TS; Korsholm L; Kristensen SR; Hallas J; Damkier P; Mickley H
Thromb Haemost; 2005 Aug; 94(2):438-43. PubMed ID: 16113837
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
[TBL] [Abstract][Full Text] [Related]
6. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
[TBL] [Abstract][Full Text] [Related]
7. A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention.
Brophy JM; Babapulle MN; Costa V; Rinfret S
Am Heart J; 2006 Aug; 152(2):263-9. PubMed ID: 16875906
[TBL] [Abstract][Full Text] [Related]
8. Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome.
Mukherjee D; Kline-Rogers E; Fang J; Munir K; Eagle KA
Heart; 2005 Jan; 91(1):23-6. PubMed ID: 15604326
[TBL] [Abstract][Full Text] [Related]
9. [Statin and clopidogrel pharmacological interaction].
Leoncini M; Toso A; Maioli M; Bellandi F
G Ital Cardiol (Rome); 2013 Sep; 14(9):574-84. PubMed ID: 23903277
[TBL] [Abstract][Full Text] [Related]
10. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
[TBL] [Abstract][Full Text] [Related]
11. Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study.
Blagojevic A; Delaney JA; Lévesque LE; Dendukuri N; Boivin JF; Brophy JM
Pharmacoepidemiol Drug Saf; 2009 May; 18(5):362-9. PubMed ID: 19253920
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction.
Lau WC; Waskell LA; Watkins PB; Neer CJ; Horowitz K; Hopp AS; Tait AR; Carville DG; Guyer KE; Bates ER
Circulation; 2003 Jan; 107(1):32-7. PubMed ID: 12515739
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic statins do not affect the antiplatelet potency of clopidogrel.
Tselepis AD; Goudevenos JA
Platelets; 2005; 16(3-4):225-6. PubMed ID: 16011971
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study.
Neubauer H; Günesdogan B; Hanefeld C; Spiecker M; Mügge A
Eur Heart J; 2003 Oct; 24(19):1744-9. PubMed ID: 14522569
[TBL] [Abstract][Full Text] [Related]
16. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
Geisler T; Zürn C; Paterok M; Göhring-Frischholz K; Bigalke B; Stellos K; Seizer P; Kraemer BF; Dippon J; May AE; Herdeg C; Gawaz M
Eur Heart J; 2008 Jul; 29(13):1635-43. PubMed ID: 18503057
[TBL] [Abstract][Full Text] [Related]
17. Platelet reactivity and clinical outcomes in patients using CYP3A4-metabolized statins with clopidogrel in percutaneous coronary intervention.
Park JS; Cha KS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Kim HS;
Heart Vessels; 2017 Jun; 32(6):690-699. PubMed ID: 27904973
[TBL] [Abstract][Full Text] [Related]
18. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4.
Polena S; Gupta MP; Shaikh H; Zazzali K; Coplan N; Gintautas J; Labana SS; Soffer D
Proc West Pharmacol Soc; 2008; 51():60-2. PubMed ID: 19544679
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
